Activatable cell-penetrating peptides: 15 years of research

被引:41
|
作者
de Jong, Heleen [1 ]
Bonger, Kimberly M. [1 ]
Loewik, Dennis W. P. M. [1 ]
机构
[1] Radboud Univ Nijmegen, Inst Mol & Mat, Dept Synthet Organ Chem, Nijmegen, Netherlands
来源
RSC CHEMICAL BIOLOGY | 2020年 / 1卷 / 04期
基金
欧洲研究理事会;
关键词
IN-VIVO; INTRACELLULAR DELIVERY; P53; UBIQUITINATION; EFFICIENT DELIVERY; OXIDATIVE STRESS; DRUG-DELIVERY; CANCER; INHIBITOR; MOLECULES; PROTEINS;
D O I
10.1039/d0cb00114g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An important hurdle for the intracellular delivery of large cargo is the cellular membrane, which protects the cell from exogenous substances. Cell-penetrating peptides (CPPs) can cross this barrier but their use as drug delivery vehicles is hampered by their lack of cell type specificity. Over the past years, several approaches have been explored to control the activity of CPPs that can be primed for cellular uptake. Since the first report on such activatable CPPs (ACPPs) in 2004, various methods of activation have been developed. Here, we provide an overview of the different ACPPs strategies known to date and summarize the benefits, drawbacks, and future directions.
引用
收藏
页码:192 / 203
页数:12
相关论文
共 50 条
  • [21] De-shielding of activatable cell-penetrating peptides: recognizing and releasing in activation process
    Chen, Binbin
    Kang, Zhengzhong
    Yao, Cai
    Zhang, Bo
    Liu, Yingchun
    Wang, Qi
    RESEARCH ON CHEMICAL INTERMEDIATES, 2021, 47 (01) : 117 - 130
  • [22] Predicting cell-penetrating peptides
    Hansen, Mats
    Kilk, Kalle
    Langel, Ulo
    ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (4-5) : 572 - 579
  • [23] The case for cell-penetrating peptides
    Asher Mullard
    Nature Reviews Drug Discovery, 2023, 22 : 615 - 616
  • [24] The biodistribution of cell-penetrating peptides
    Sarko, D.
    Boy, R. Garcia
    Knapp, E.
    Eisenhut, M.
    Haberkorn, U.
    Mier, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S320 - S320
  • [25] Prediction of cell-penetrating peptides
    Hällbrink, M
    Kilk, K
    Elmquist, A
    Lundberg, P
    Lindgren, M
    Jiang, Y
    Pooga, M
    Soomets, U
    Langel, Ü
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2005, 11 (04) : 249 - 259
  • [26] Cell dependent cell-penetrating peptides
    Shi, Junfeng
    Schneider, Joel
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [27] Gelatinase activity imaged by activatable cell-penetrating peptides in cell-based and in vivo models of stroke
    Chen, Shanyan
    Cui, Jiankun
    Jiang, Tao
    Olson, Emilia S.
    Cai, Quan-Yu
    Yang, Ming
    Wu, Wei
    Guthrie, James M.
    Robertson, J. D.
    Lipton, Stuart A.
    Ma, Lixin
    Tsien, Roger Y.
    Gu, Zezong
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2017, 37 (01): : 188 - 200
  • [28] In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity
    Olson, Emilia S.
    Whitney, Michael A.
    Friedman, Beth
    Aguilera, Todd A.
    Crisp, Jessica L.
    Baik, Fred M.
    Jiang, Tao
    Baird, Stephen M.
    Tsimikas, Sotirios
    Tsien, Roger Y.
    Nguyen, Quyen T.
    INTEGRATIVE BIOLOGY, 2012, 4 (06) : 595 - 605
  • [29] Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides
    Aguilera, Todd A.
    Olson, Emilia S.
    Timmers, Margaret M.
    Jiang, Tao
    Tsien, Roger Y.
    INTEGRATIVE BIOLOGY, 2009, 1 (5-6) : 371 - 381
  • [30] Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics
    Heitz, Frederic
    Morris, May Catherine
    Divita, Gilles
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (02) : 195 - 206